Your browser doesn't support javascript.
loading
Tissue-engineered heart valve: future of cardiac surgery.
Rippel, Radoslaw A; Ghanbari, Hossein; Seifalian, Alexander M.
Afiliación
  • Rippel RA; UCL Centre for Nanotechnology & Regenerative Medicine, Division of Surgery and Interventional Science, University College London, London, UK. r.rippel@ucl.ac.uk
World J Surg ; 36(7): 1581-91, 2012 Jul.
Article en En | MEDLINE | ID: mdl-22395345
BACKGROUND: Heart valve disease is currently a growing problem, and demand for heart valve replacement is predicted to increase significantly in the future. Existing "gold standard" mechanical and biological prosthesis offers survival at a cost of significantly increased risks of complications. Mechanical valves may cause hemorrhage and thromboembolism, whereas biologic valves are prone to fibrosis, calcification, degeneration, and immunogenic complications. METHODS: A literature search was performed to identify all relevant studies relating to tissue-engineered heart valve in life sciences using the PubMed and ISI Web of Knowledge databases. DISCUSSION: Tissue engineering is a new, emerging alternative, which is reviewed in this paper. To produce a fully functional heart valve using tissue engineering, an appropriate scaffold needs to be seeded using carefully selected cells and proliferated under conditions that resemble the environment of a natural human heart valve. Bioscaffold, synthetic materials, and preseeded composites are three common approaches of scaffold formation. All available evidence suggests that synthetic scaffolds are the most suitable material for valve scaffold formation. Different cell sources of stem cells were used with variable results. Mesenchymal stem cells, fibroblasts, myofibroblasts, and umbilical blood stem cells are used in vitro tissue engineering of heart valve. Alternatively scaffold may be implanted and then autoseeded in vivo by circulating endothelial progenitor cells or primitive circulating cells from patient's blood. For that purpose, synthetic heart valves were developed. CONCLUSIONS: Tissue engineering is currently the only technology in the field with the potential for the creation of tissues analogous to a native human heart valve, with longer sustainability, and fever side effects. Although there is still a long way to go, tissue-engineered heart valves have the capability to revolutionize cardiac surgery of the future.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bioprótesis / Prótesis Valvulares Cardíacas / Ingeniería de Tejidos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: World J Surg Año: 2012 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bioprótesis / Prótesis Valvulares Cardíacas / Ingeniería de Tejidos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: World J Surg Año: 2012 Tipo del documento: Article